It should be emphasized that the ClinGen RASopathy Expert Panel defined the SOS1 gene to be a gene with a low rate of benign missense variants and high number of pathogenic missense variants, also highlighting that K170E variant is in a location that has been defined to be a mutational hotspot of SOS1 [10]. This evidence concerns the gene SOS1 and RASopathy.